Quest Diagnostics CEO Stephen Rusckowski's 2018 pay slips 4% to $10M
Quest Diagnostics reports 2018 executive compensation
By ExecPay News
Published: April 3, 2019
Quest Diagnostics reported fiscal year 2018 executive compensation information on April 3, 2019.
In 2018, five executives at Quest Diagnostics received on average a compensation package of $4.3M, a 3% decrease compared to previous year.
Average pay of disclosed executives at Quest Diagnostics
Stephen H. Rusckowski, Chief Executive Officer, received $10M in total, which decreased by 4% compared to 2017. 47% of Rusckowski's compensation, or $4.7M, was in stock awards. Rusckowski also received $789K in non-equity incentive plan, $3.1M in option awards, $1.1M in salary, as well as $315K in other compensation.
Mark J. Guinan, Chief Financial Officer, received a compensation package of $3.2M, which decreased by 7% compared to previous year. 43% of the compensation package, or $1.4M, was in stock awards.
James E. Davis, Executive Vice President, General Diagnostics, earned $3.1M in 2018, a 6% decrease compared to previous year.
Carrie Eglinton Manner, Senior Vice President, Advanced Diagnostics, received $2.9M in 2018, which increases by 10% compared to 2017.
Catherine T. Doherty, Senior Vice President, Group Executive Clinical Franchises, earned $2.3M in 2018, a 8% decrease compared to previous year.
Related executives
Stephen Rusckowski
Quest Diagnostics
Chief Executive Officer
Mark Guinan
Quest Diagnostics
Chief Financial Officer
James Davis
Quest Diagnostics
Chief Executive Officer
Carrie Manner
Quest Diagnostics
Senior Vice President, Advanced and General Diagnostics and Clinical Solutions
Catherine Doherty
Quest Diagnostics
Senior Vice President, Regional Businesses
You may also like
Source: SEC filing on April 3, 2019.